Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat

AIMS: The long-term efficacy of epalrestat, an aldose reductase inhibitor, in improving subjective symptoms and nerve function was comprehensively assessed to identify patients with diabetic peripheral neuropathy who responded to epalrestat treatment. METHODS: Stratified analyses were conducted on d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hotta, N, Kawamori, R, Atsumi, Y, Baba, M, Kishikawa, H, Nakamura, J, Oikawa, S, Yamada, N, Yasuda, H, Shigeta, Y
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Article: Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613255/
https://www.ncbi.nlm.nih.gov/pubmed/18644069
http://dx.doi.org/10.1111/j.1464-5491.2008.02490.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613255/
https://www.ncbi.nlm.nih.gov/pubmed/18644069
http://dx.doi.org/10.1111/j.1464-5491.2008.02490.x

Ejemplares similares